Cardiex Ltd
ASX:CDX
Operating Margin
Cardiex Ltd
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin Across Competitors
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| AU |
|
Cardiex Ltd
ASX:CDX
|
22.6m AUD |
-405%
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
216.5B USD |
18%
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
185B USD |
28%
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
153.5B USD |
19%
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
148B USD |
22%
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
115B USD |
20%
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
51.2B EUR |
14%
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
50.3B USD |
13%
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
45.1B USD |
28%
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
42.1B USD |
29%
|
|
| US |
|
Resmed Inc
NYSE:RMD
|
38.3B USD |
32%
|
Cardiex Ltd
Glance View
CardieX Ltd. is engaged in the designing, manufacturing, and marketing of medical devices for use in cardiovascular health management. The company is headquartered in Sydney, New South Wales. The company went IPO on 2005-11-09. The firm is focused on designing, manufacturing and marketing medical devices for use in cardiovascular health management. The company operates through its subsidiaries, including ATCOR and CONNEQT. The firm's ATCOR division provides medical devices for measuring arterial stiffness and central blood pressure waveforms based on its FDA-cleared and patented SphygmoCor technology. Under the ATCOR.X brand, the Company also develops and licenses its Arty platform consisting of physiological and health analytics for wearable devices. The firm's digital platform, ArtyNet, is a connected software as a service ecosystem providing physicians with a telehealth solution for remotely managing patients' health. CONNEQT develops and markets consumer wearable and home health devices focused on heart health and its patented fitness and wellness parameters.
See Also
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Based on Cardiex Ltd's most recent financial statements, the company has Operating Margin of -404.8%.
You don't have any saved screeners yet